KCL-286

• Description :

  KCL-286 is an orally available and potent retinoic acid receptor beta agonist for the amelioration of spinal cord injury (SCI) .

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  334.33

• Molecular Formula :

  C19H14N2O4

• Notes :

  Research use only, not for human use.

• Receptor :

  Retinoid Receptor

• CAS Number :

  1952276-71-9